Skip to main content

Articles By Jack Cush, MD

RheumNow Podcast square

Great and Not So Great (9.30.2022)

30 September 2022

This week it's the great and not-so-great on gout, chondrocalcinosis, osteoporosis and misdiagnosis. We are good at many of those things - what's not so great? Let's review the news and journal reports from the past week on RheumNow.

Read Article
coronavirus,COVID,MISC,mask

COVID-19 Arthropathy and Myalgia

30 September 2022

An online survey of random COVID-19 infected persons shows that arthralgia and myalgia are common consequences to COVID-19 infection.

Read Article
narcotic%20pills.jpg

Opioid Crisis Costs USA $1.5 Trillion

29 September 2022

Reuters has reported the results of a Congressional report showing the economic toll of the opioid addiction and overdose crisis on the United States reached nearly $1.5 trillion in 2020 alone and is likely to grow.

Read Article
JAK Janus

Efficacy and Safety of JAK Inhibitors in Psoriatic Disease

28 September 2022

There is a growing body of evidence demonstrating efficacy and safety of JAK inhibitors in patients with moderate-to-severe psoriasis and psoriatic arthritis, according to a systematic review in BMC Rheumatology.

Read Article
joint.pain_.hand_.PIP_.jpg

Uncommon Misdiagnosis of Rheumatoid Arthritis

28 September 2022

Using long-term patient data from the BARFOT study of early rheumatoid arthritis (RA) patients, researchers at the Karolinska Institute have shown that use of the ACR-1987 classification criteria was highly precise.

Read Article
sleep,man,dream

Immune Benefits to Sound Sleep

26 September 2022

The revitalizing powers of sleep are numerous but what are the consequences to inadequate sleep? A current report in the Journal of Experimental Medicine shows the connection between sleep and immune function as measured in mice and humans; specifically, a good night’s sleep promotes normal production and programming of hematopoietic stem cells. 

Read Article
RheumNow Podcast square

Heavy Metal Rheumatology (9.23.2022)

23 September 2022

Below are this week’s highlights from RheumNow, as discussed by Dr. Jack Cush. Thanks to all of you for your kind comments and great reviews of our weekly podcast. Please let us know how we can improve by emailing me or recording your suggestion using the "Ask Cush Anything" link on our website.

Read Article
PSS.hands_.Raynauds.jpg (keep)

Cancer Risk with Scleroderma

22 September 2022

Spanish Scleroderma Registry examined a large cohort of systemic sclerosis (SSc) patients showing an increased cancer risk, especially breast, lung, hematologic and colorectal cancer. The registry included 1930 patients with SSc and were compared to a matched general population to derive the standardized incidence ratios (SIRs) and independent cancer risk factors.

Read Article
voices.jpg

USPSTF Recommends Screening for Anxiety and Depression

22 September 2022

The U.S. Preventive Services Task Force has recommended that general practitioners actively screen and identify anxiety and depression in all adult patients under 65 yrs.

Read Article
antibody (Keep)

Clinical Profiles Seen with NXP-2 Antibodies

20 September 2022

A recent review of the myositis associated autoantibody NXP-2 profiles its clinical associations with dermatomyositis (DM), calcinosis, severe myositis and, in some reports, with cancer.

Read Article
×